Open Access 01-12-2015 | Study protocol
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
Published in: BMC Cancer | Issue 1/2015
Login to get access